Company intelligence / Profile preview

Kura Biotech

Los Lagos Region, Chilekurabiotech.com ↗

Ownership: Private
Employees: ~76
Development stage: Commercial

Overview

Kura Biotech develops and commercializes proprietary enzymatic tools to streamline laboratory sample preparation workflows. Their products are used globally in toxicology, genomics, proteomics, and food safety testing. The company has won innovation awards for its pathogen detection kits and supplies major laboratories worldwide with ISO-certified enzymes. They are recognized as a Certified B Corporation with a strong social impact mission.

Therapeutic areas: OtherInfectious Diseases
Modalities: Enzymes for sample preparation (toxicology, genomics, proteomics)Not directly therapeutic modalities like small molecules or mAbs; focus on research tools and diagnostics.
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Kura Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kura Biotech.

Explore the full profile